Taken together, these observations provide the characterization of various pharmacological inhibitors of NLRP3 inflammasome activation in CLD (Table 1), thereby supporting the importance of the NLRP3 inflammasome signaling cascade in the development of CLD. Here, NLRP3 is linked to congenital secretory chloride diarrhea 1.